Clorox (CLX) Expected to Announce Earnings on Monday

Clorox (NYSE:CLX) is projected to post its quarterly earnings results after the market closes on Monday, February 3rd. Analysts expect Clorox to post earnings of $1.39 per share and revenue of $1,626,355.48 billion for the quarter. Clorox has set its FY25 guidance at $6.65-$6.90 EPS and its FY 2025 guidance at 6.650-6.900 EPS.Investors interested in registering for the company’s conference call can do so using this link.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the company posted $0.49 EPS. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Clorox Price Performance

Shares of Clorox stock opened at $159.12 on Monday. The firm has a market cap of $19.70 billion, a PE ratio of 55.44, a P/E/G ratio of 2.92 and a beta of 0.42. The business has a 50-day moving average price of $163.66 and a 200 day moving average price of $157.50. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.07%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on CLX shares. Barclays dropped their price target on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, JPMorgan Chase & Co. boosted their price objective on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday, January 16th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.